ConductScience.org, home

Paper39025972

Malaria vaccines: a new era of prevention and control.

Duffy PE and 3 others. Nat Rev Microbiol, 2024. Cited by 92 papers, by iCite.

Cite this record

ConductScience Library. Malaria vaccines: a new era of prevention and control. Papers, record 39025972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39025972

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Malaria vaccines: a new era of prevention and control.
PubMed
Journal
Nat Rev Microbiol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
92
iCite
Relative citation ratio, by iCite
15.52, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Duffy PEPatrick Ehttps://orcid.org/0000-0002-4483-5005
2Gorres JPJ Patrick
3Healy SASara A
4Fried MMichal

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Malaria VaccinesMajor topic
MalariaMajor topic
Humans
Animals
Plasmodium
Plasmodium vivax
Pregnancy

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
ZIAAI001008NIHNIH RePORTER
ZIAAI001056NIHNIH RePORTER

Download CSV of grants

References180

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132183832Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali.Reprod Health2020https://conductscience.org/library/papers/32183832PubMed
216861644
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Infect Immun2006https://conductscience.org/library/papers/16861644PubMed
336087586Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.Lancet Infect Dis2022https://conductscience.org/library/papers/36087586PubMed
436708738Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.Lancet Infect Dis2023https://conductscience.org/library/papers/36708738PubMed
535963275
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults.
Lancet Infect Dis2022https://conductscience.org/library/papers/35963275PubMed
626063320Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.Sci Rep2015https://conductscience.org/library/papers/26063320PubMed
734223402Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.Med2021https://conductscience.org/library/papers/34223402PubMed
827296848Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.J Infect Dis2016https://conductscience.org/library/papers/27296848PubMed
927132023Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells.Clin Immunol2016https://conductscience.org/library/papers/27132023PubMed
1033686061Predicting the public health impact of a malaria transmission-blocking vaccine.Nat Commun2021https://conductscience.org/library/papers/33686061PubMed
1135293561Plasmodium falciparum merozoite surface protein 3 as a vaccine candidate: a brief review.Rev Inst Med Trop Sao Paulo2022https://conductscience.org/library/papers/35293561PubMed
1217124530Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.PLoS Clin Trials2006https://conductscience.org/library/papers/17124530PubMed
1332724063Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines.Sci Rep2020https://conductscience.org/library/papers/32724063PubMed
14406671An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum.Science1977https://conductscience.org/library/papers/406671PubMed
1537474653mRNA vaccine against malaria tailored for liver-resident memory T cells.Nat Immunol2023https://conductscience.org/library/papers/37474653PubMed
1632566259Malaria vaccines since 2000: progress, priorities, products.NPJ Vaccines2020https://conductscience.org/library/papers/32566259PubMed
1731092823Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.Nat Commun2019https://conductscience.org/library/papers/31092823PubMed
1826254338Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.J Immunol2015https://conductscience.org/library/papers/26254338PubMed
1933964223Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.Lancet2021https://conductscience.org/library/papers/33964223PubMed
2015051281A large focus of naturally acquired Plasmodium knowlesi infections in human beings.Lancet2004https://conductscience.org/library/papers/15051281PubMed

See all 180 referencesDownload CSV of references

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.

PMIDTitleJournalYearIn PapersSource
42869939Mosquito-based malaria control through genetic, microbial and immunological innovations.Nat Rev Microbiol2026https://conductscience.org/library/papers/42869939PubMed
42804534Proteome-wide characterization of Plasmodium vivax antigens using a high-density peptide array.PLoS Pathog2026https://conductscience.org/library/papers/42804534PubMed
42684012Malaria Prevalence Near African Mangroves: Negative Association With Mangrove Extent, but Positive Association With Mangrove Greenness.Glob Chang Biol2026https://conductscience.org/library/papers/42684012PubMed
42592156Noninvasive malaria detection beyond blood sampling.Sens Diagn2026https://conductscience.org/library/papers/42592156PubMed
42455589A Global Perspective of Childhood Vaccinations: Past, Present, and Future-From Smallpox to mRNA.Acta Paediatr2026https://conductscience.org/library/papers/42455589PubMed
42453291Effectiveness of the Smart Home Model for Integrated Malaria Prevention: A Case-Control Study in Oyam District, Uganda.J Trop Med2026https://conductscience.org/library/papers/42453291PubMed
42387124Seeking universal malaria-vaccine targets.Nature2026https://conductscience.org/library/papers/42387124PubMed
42295386Highly sensitive detection of species-specific malaria antigens using a cellulose nanobead-based lateral flow immunoassay.Mikrochim Acta2026https://conductscience.org/library/papers/42295386PubMed
42234703Structural basis for conserved and distinct antigen recognition by a lineage of malaria-protective antibodies.PLoS Pathog2026https://conductscience.org/library/papers/42234703PubMed
42227058Plasmepsins as Antimalarial Drug Targets-Then, Now, and the Future.Med Res Rev2026https://conductscience.org/library/papers/42227058PubMed
42199930Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold.iScience2026https://conductscience.org/library/papers/42199930PubMed
42059554Paclitaxel-induced tubulin dysfunction stalls parasite development: synergistic potential with artemisinin against resistant strains.Microbiol Spectr2026https://conductscience.org/library/papers/42059554PubMed
41980931Potent acridone antimalarial against all three life stages of Plasmodium.Nat Commun2026https://conductscience.org/library/papers/41980931PubMed
41977140Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice.Int J Mol Sci2026https://conductscience.org/library/papers/41977140PubMed
41972578Malaria in the 21st Century: Global Disease Burden, Epidemiological Insights, and Strategic Control Approaches.Biology (Basel)2026https://conductscience.org/library/papers/41972578PubMed
41970896Indole Peptidomimetics Show Potent and Selective Activity against Drug-Resistant Plasmodium falciparum.ACS Omega2026https://conductscience.org/library/papers/41970896PubMed
41961468Lymphoid-Tissue-on-Chip Recapitulates Human Antibody Responses In Vitro.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41961468PubMed
41923211Distribution of Plasmodium falciparum apical membrane antigen-1 cluster one loop haplotypes and their association with malaria symptoms in Bandiagara, Mali.BMC Infect Dis2026https://conductscience.org/library/papers/41923211PubMed
41893813Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.Vaccines (Basel)2026https://conductscience.org/library/papers/41893813PubMed
41851575Advancing global malaria control: therapeutic strategies, drug discovery, and formulation innovations.Infection2026https://conductscience.org/library/papers/41851575PubMed

See all 62 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39025972

GET https://conductscience.org/api/papers/v1/39025972/references?page=2